Literature DB >> 21242886

Introduction: challenges to finding a cure for HIV infection.

Douglas D Richman1.   

Abstract

PURPOSE OF REVIEW: Renewed interest has emerged to address the latent reservoir of HIV to achieve a cure. RECENT
FINDINGS: The integrated proviral genome is a fundamental component of the retroviral replication cycle. The establishment of latently infected CD4+ lymphocytes, and perhaps other as yet poorly characterized cells, represents a reservoir of HIV infection that is not appreciably affected by effective antiretroviral chemotherapy. Effective management of HIV infection, thus, will require lifelong treatment unless an approach to purging this reservoir is identified. Although substantial insights about the latent reservoir have been made, our understanding about the details of the reservoirs, the mechanisms of latency and potential targets to eliminate latently infected cells is too primitive to achieve a cure without a great deal of basic research to elucidate some of these areas.
SUMMARY: A resurgence of interest in latent infection and its treatment promises progress in addressing the challenge of a cure, although, realistically, this will require a prolonged period of investigation in many areas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242886      PMCID: PMC3077900          DOI: 10.1097/COH.0b013e328340ffa6

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  11 in total

1.  HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.

Authors:  M Hermankova; S C Ray; C Ruff; M Powell-Davis; R Ingersoll; R T D'Aquila; T C Quinn; J D Siliciano; R F Siliciano; D Persaud
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

Review 2.  Experimental approaches to the study of HIV-1 latency.

Authors:  Yefei Han; Megan Wind-Rotolo; Hung-Chih Yang; Janet D Siliciano; Robert F Siliciano
Journal:  Nat Rev Microbiol       Date:  2007-02       Impact factor: 60.633

3.  Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.

Authors:  Michael W Melkus; Jacob D Estes; Angela Padgett-Thomas; Joel Gatlin; Paul W Denton; Florence A Othieno; Anja K Wege; Ashley T Haase; J Victor Garcia
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

Review 4.  The challenge of finding a cure for HIV infection.

Authors:  Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz
Journal:  Science       Date:  2009-03-06       Impact factor: 47.728

5.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

Authors:  T W Chun; L Carruth; D Finzi; X Shen; J A DiGiuseppe; H Taylor; M Hermankova; K Chadwick; J Margolick; T C Quinn; Y H Kuo; R Brookmeyer; M A Zeiger; P Barditch-Crovo; R F Siliciano
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

6.  Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.

Authors:  Justin R Bailey; Ahmad R Sedaghat; Tara Kieffer; Timothy Brennan; Patricia K Lee; Megan Wind-Rotolo; Christine M Haggerty; Ashrit R Kamireddi; Yi Liu; Jessica Lee; Deborah Persaud; Joel E Gallant; Joseph Cofrancesco; Thomas C Quinn; Claus O Wilke; Stuart C Ray; Janet D Siliciano; Richard E Nettles; Robert F Siliciano
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Novel pathway for induction of latent virus from resting CD4(+) T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency.

Authors:  Anding Shen; Hung-Chih Yang; Yan Zhou; Amanda J Chase; Jean D Boyer; Hao Zhang; Joseph B Margolick; M Christine Zink; Janice E Clements; Robert F Siliciano
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

8.  Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads.

Authors:  Tara L Kieffer; Mariel M Finucane; Richard E Nettles; Thomas C Quinn; Karl W Broman; Stuart C Ray; Deborah Persaud; Robert F Siliciano
Journal:  J Infect Dis       Date:  2004-04-05       Impact factor: 5.226

9.  HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.

Authors:  Christoph C Carter; Adewunmi Onafuwa-Nuga; Lucy A McNamara; James Riddell; Dale Bixby; Michael R Savona; Kathleen L Collins
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

10.  Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads.

Authors:  Deborah Persaud; George K Siberry; Aima Ahonkhai; Joleen Kajdas; Daphne Monie; Nancy Hutton; Douglas C Watson; Thomas C Quinn; Stuart C Ray; Robert F Siliciano
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more
  8 in total

1.  Optimization of benzyloxazoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase to enhance Y181C potency.

Authors:  Mariela Bollini; Ricardo Gallardo-Macias; Krasimir A Spasov; Julian Tirado-Rives; Karen S Anderson; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2012-12-12       Impact factor: 2.823

Review 2.  Eliminating the HIV reservoir.

Authors:  Alain Lafeuillade
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 3.  How to best measure HIV reservoirs?

Authors:  Christine Rouzioux; Douglas Richman
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

4.  Synaptic transmission may provide an evolutionary benefit to HIV through modulation of latency.

Authors:  Cesar Vargas-Garcia; Ryan Zurakowski; Abhyudai Singh
Journal:  J Theor Biol       Date:  2018-07-23       Impact factor: 2.691

5.  Generation of HIV latency in humanized BLT mice.

Authors:  Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

6.  Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis.

Authors:  Noëlie Campos; Renier Myburgh; Aude Garcel; Audrey Vautrin; Laure Lapasset; Erika Schläpfer Nadal; Florence Mahuteau-Betzer; Romain Najman; Pauline Fornarelli; Katjana Tantale; Eugénia Basyuk; Martial Séveno; Julian P Venables; Bernard Pau; Edouard Bertrand; Mark A Wainberg; Roberto F Speck; Didier Scherrer; Jamal Tazi
Journal:  Retrovirology       Date:  2015-04-09       Impact factor: 4.602

Review 7.  Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications.

Authors:  Chet Raj Ojha; Jessica Lapierre; Myosotys Rodriguez; Seth M Dever; Mohammad Asad Zadeh; Catherine DeMarino; Michelle L Pleet; Fatah Kashanchi; Nazira El-Hage
Journal:  Viruses       Date:  2017-07-06       Impact factor: 5.048

8.  HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.

Authors:  Will Dampier; Michael R Nonnemacher; Joshua Mell; Joshua Earl; Garth D Ehrlich; Vanessa Pirrone; Benjamas Aiamkitsumrit; Wen Zhong; Katherine Kercher; Shendra Passic; Jean W Williams; Jeffrey M Jacobson; Brian Wigdahl
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.